Home Cart Sign in  
Chemical Structure| 54857-86-2 Chemical Structure| 54857-86-2

Structure of TOFA
CAS No.: 54857-86-2

Chemical Structure| 54857-86-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TOFA is a potent, reversible and competitive acetyl-CoA carboxylase (ACC) inhibitor which can inhibit fatty acid synthesis.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TOFA

CAS No. :54857-86-2
Formula : C19H32O4
M.W : 324.46
SMILES Code : O=C(C1=CC=C(OCCCCCCCCCCCCCC)O1)O
MDL No. :MFCD01726059
InChI Key :CZRCFAOMWRAFIC-UHFFFAOYSA-N
Pubchem ID :115175

Safety of TOFA

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of TOFA

ferroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Daudi cells 0.3, 1, 3, 10 μg/mL 24-48 hours Inhibition of lipogenesis leads to apoptosis Cancer Metab. 2021 Aug 16;9(1):31.
P493-6 cells 0.3, 1, 3, 10 μg/mL 24-48 hours Inhibition of lipogenesis leads to apoptosis Cancer Metab. 2021 Aug 16;9(1):31.
4188 cells 0.3, 1, 3, 10 μg/mL 24-48 hours Inhibition of lipogenesis leads to apoptosis Cancer Metab. 2021 Aug 16;9(1):31.
CD8+ T cells 1 µM 5 days Inhibited CD8+ T cell proliferation J Transl Med. 2023 Jul 4;21(1):434.
CD8+ T cells 1 µM Decreased IFN-γ, granzyme B, perforin levels J Transl Med. 2023 Jul 4;21(1):434.
CD8+ T cells 1 µM 24 hours Reduced CD69 membrane expression J Transl Med. 2023 Jul 4;21(1):434.
K562 cells 0.3, 1, 3, 10 μg/mL 24-48 hours Inhibition of lipogenesis leads to apoptosis Cancer Metab. 2021 Aug 16;9(1):31.
Ramos cells 0.3, 1, 3, 10 μg/mL 24-48 hours Inhibition of lipogenesis leads to apoptosis Cancer Metab. 2021 Aug 16;9(1):31.
BSC40 cells 154 µM 16 hours To evaluate the impact of TOFA on vaccinia virus yield. Results showed TOFA significantly inhibited viral yield by 95-fold, with partial rescue (8-fold) provided by exogenous palmitate. PLoS Pathog. 2014 Mar 20;10(3):e1004021.
PBMCs 0.08–2 µM 2 days TOFA reversed Th17/Treg imbalance and inhibited IL-2–induced STAT1/3 phosphorylation. JCI Insight. 2022 Dec 8;7(23):e162335.
HEK-293T cells 5 µM 23 hours Combination of TOFA with pimozide significantly enhanced antiviral effects. Nat Commun. 2016 May 12;7:11320.
PBMCs 0.08–10 µM 24 hours TOFA cytotoxicity was assessed using a CCK8 assay, and we found no substantial cytotoxicity of the drug when concentrations less than 10 μM were used. JCI Insight. 2022 Dec 8;7(23):e162335.
CCRF-CEM cells 0.3, 1, 3, 10 μg/mL 24-48 hours Inhibition of lipogenesis leads to apoptosis Cancer Metab. 2021 Aug 16;9(1):31.
Human bone marrow-derived stromal cells (hBMSCs) 200, 400, or 800 nM 3 days Under non-inflammatory conditions, Tofa treatment significantly decreased the gene expression of Runx2 and Dlx5 (p <0.05) and increased the gene expression of PPAR g2, C/EBPa, and Perilipin 1 (p <0.05). Under inflammatory conditions, Tofa limited the negative effect of TNF a on BMAd differentiation (p <0.05). Front Endocrinol (Lausanne). 2022 Jul 6;13:881699.
Human naive CD4 T cells 10 µM 4 days TOFA significantly increased IL-9 production by inhibiting ACC1 and reduced the proportion of Foxp3+ cells. Exogenous oleic acid restored IL-9 levels in TOFA-treated cells. Front Immunol. 2024 Dec 23;15:1509408.
Normal human epidermal keratinocytes (NHEKs) 1 µM 48 hours Inhibited production and secretion of CXCL9 and CXCL10 J Transl Med. 2023 Jul 4;21(1):434.
U2OS cells 10 µM 48 hours TOFA inhibited lipid accumulation, promoted early slippage, reduced cellular stress and enhanced survival of antimitotic-treated cells Cell Death Discov. 2018 Nov 27;4:109.
Rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) 2.5 µM 48 hours Investigate the effects of TOFA on gene expression in RA-FLS, showing that TOFA primarily downregulated gene expression, affecting interferon signaling pathways. Arthritis Res Ther. 2024 Oct 11;26(1):178.
U87 cells 39.98 µM (IC50) 5 days TOFA showed an IC50 value of 39.98 µM for U87 cells, indicating inhibitory effects on TMZ-sensitive cells. Acta Pharmacol Sin. 2023 Mar;44(3):670-679.
U87R cells 7.51 µM (IC50) 5 days TOFA showed an IC50 value of 7.51 µM for U87R cells, indicating inhibitory effects on TMZ-resistant cells. Acta Pharmacol Sin. 2023 Mar;44(3):670-679.
HeLa cells 25 µM 7 hours TOFA significantly reduced viral RNA synthesis and release, with no significant effect on cell viability. Nat Commun. 2016 May 12;7:11320.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Cecal ligation and perforation (CLP)-induced sepsis model Intragastric administration 1 mg/kg, 3 mg/kg, 10 mg/kg Every 6 hours for 7 days To evaluate the effect of TOFA on the survival rate of septic rats and its role in acute lung injury. The results showed that TOFA (10 mg/kg) significantly improved the survival rate of septic rats and reduced lung histopathological damage and inflammatory factor expression J Inflamm (Lond). 2023 Feb 3;20(1):5
New Zealand white rabbits Experimental rheumatoid arthritis (e-RA) Oral 10 mg/kg Once daily for two weeks To evaluate the effect of JAK inhibitors on muscle remodeling in an experimental RA model. TOFA significantly improved muscle mass and structural parameters, reduced the expression of muscle atrophy-related genes, and increased creatine kinase (CK) levels in muscle. Int J Mol Sci. 2023 Aug 24;24(17):13181
New Zealand white rabbits Antigen-induced arthritis model Oral gavage 10 mg/kg Once daily for 2 weeks To investigate the early effects of TOFA on intra-joint JAK/STAT-dependent signaling during flare-up reactions in arthritis. Results showed that TOFA partially improved synovitis, reduced levels of pSTAT1 and SOCS1, but had no effect on pSTAT3 or SOCS3. J Inflamm (Lond). 2019 Jan 29;16:2
C57BL/6 mice Adult Mice footpad injection model Intraperitoneal injection 25 mg/kg Pretreated for at least 3 days before infection and assessed 18 h p.i. TOFA significantly reduced CHIKV replication. Nat Commun. 2016 May 12;7:11320.
C57BL6/J mice GPx1/2-DKO Mice model Oral 30 mg/kg Once daily for 6 or 13 days To evaluate the efficacy of TOFA on very-early-onset ileocolitis in GPx1/2-DKO mice. Results showed that TOFA significantly inhibited crypt apoptosis and increased crypt density, but did not affect Mice growth. Life Sci. 2019 Dec 15;239:116884
C57BL/6 mice Vitiligo Mice model Intraperitoneal injection 5 mg/kg Once every other day for five weeks Alleviated the extent of depigmentation and reduced CD8+ T cell skin infiltration J Transl Med. 2023 Jul 4;21(1):434.
Mice NSG mice Intraperitoneal injection 5.5 μg/ml 4 days Inhibition of lipogenesis delays tumor progression Cancer Metab. 2021 Aug 16;9(1):31.
Lewis rats Fisher-to-Lewis rat model of kidney transplantation Oral (mixed with food) 50 mg/kg and 100 mg/kg From the third week post-transplantation until the end of the study (12 weeks) TOFA prolonged graft survival, preserved tubular and glomerular structures and reduced humoral damage characterized by C4d deposition. TOFA was able to reduce donor-specific antibodies. In addition, T and natural killer (NK) cell graft infiltration was reduced in TOFA-treated rats. Transplantation. 2018 Jul;102(7):1075-1084

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.08mL

0.62mL

0.31mL

15.41mL

3.08mL

1.54mL

30.82mL

6.16mL

3.08mL

References

 

Historical Records

Categories